Related Experiment Videos
Ali Yildirim1, Heinz-Theo Lübbers, Ayhan Yildirim
1Clinique danesthésiologie, de médecine intensive, durgence et de la douleur, Hôpital cantonal de SaintGall, Saint-Gall, Switzerland.
Insights
Acute coronary syndrome (ACS) begins with atherosclerotic plaque rupture, often leading to myocardial infarction. Early management, including antiplatelet and anticoagulant therapy, is crucial for improving patient prognosis and preventing further clot formation.
Area of Science:
- Cardiology
- Vascular Biology
- Emergency Medicine
Background:
- Acute coronary syndrome (ACS) is commonly initiated by the rupture of atherosclerotic plaques.
- This rupture can lead to persistent thrombotic occlusion, resulting in acute myocardial infarction.
- Effective early patient management significantly impacts ACS prognosis.
Purpose of the Study:
- To outline the essential components of early management for acute coronary syndrome.
- To emphasize the role of antithrombotic therapy in preventing further thrombotic events.
Main Methods:
- Review of established clinical guidelines and practices for acute coronary syndrome management.
- Focus on the pharmacological interventions for plaque rupture complications.
Main Results:
- Early pain relief is a critical aspect of acute coronary syndrome management.
- Initiation of antithrombotic therapy, including antiplatelet and anticoagulant agents like aspirin and heparin, is essential.
- This therapy aims to prevent further thrombosis and embolism from ulcerated plaques.
Conclusions:
- Prompt and appropriate management of acute coronary syndrome, particularly antithrombotic therapy, is vital for improving patient outcomes.
- Preventing further clot formation and embolism is a key goal in the acute phase of ACS.
Abstract:
Rupture of an atherosclerotic plaque is the usual initiating event in an acute coronary syndrome (ACS). Persistent thrombotic occlusion at the site of plaque rupture results in acute myocardial infarction. The early management of the patient is essential and crucially affects the prognosis of an ACS. Management includes the relief of ischemic pain and the initiation of an antithrombotic therapy, including an antiplatelet and anticoagulant therapy with aspirin and heparin to prevent further thrombosis of or embolism from an ulcerated plaque.